期刊文献+

HPLC测定消炎止痢灵片中甲氧苄啶的溶出度

Determination of the dissolution of trimethoprim in Xiaoyan Zhililing tablets by HPLC
原文传递
导出
摘要 目的测定消炎止痢灵片中甲氧苄啶的溶出度。方法采用桨法,以0.01 mol·L^-1盐酸为溶出介质,转速为75 r·min^-1,取样时间60 min。HPLC法采用Zorbax SB-C18(150 mm×4.6 mm,5μm)色谱柱,以甲醇-0.01 mol·L^-1乙酸铵溶液(33∶67)为流动相,检测波长235 nm,流速1.0 m L·min^-1,柱温为25℃。结果甲氧苄啶0.0812~0.812μg与峰面积呈现良好的线性关系(r=0.9991),平均回收率97.8%,RSD=1.09%(n=9)。结论所用方法简便、准确、可行,能用于消炎止痢灵片中甲氧苄啶的溶出度测定。 OBJECTIVE To detect the dissolution of trimethoprim from Xiaoyan Zhililing tablets. METHODS Paddle apparatus was used with 0. 01 mol·L^-1hydrochloric acid solution as the dissolution medium at a speed of 75 r·min^-1,and dissolution time limit was 60 min. The analysis was carried out on a Zorbax SB- C18( 150 mm × 4. 6 mm,5 μm) column,the mobile phase was composed of methanol- 0. 01 mol·L^-1ammonium acetate( 33∶67) at the flow rate of 1. 0 m L·min^-1,and the detection wavelength was at 235 nm.And the column temperature was 25 ℃. RESULTS Trimethoprim at the range of 0. 0812- 0. 812 μg showed good linearity( r =0. 9991). The average recovery was 97. 8% with the RSD of 1. 09%( n = 9). CONCLUSION The method is convenient,accurate and practicable. It can be applied to determine the dissolution of the preparations.
出处 《华西药学杂志》 CAS CSCD 2016年第2期194-196,共3页 West China Journal of Pharmaceutical Sciences
关键词 消炎止痢灵片 甲氧苄啶 高效液相色谱法 溶出度 浆法 Xiaoyan Zhililing tablets Trimethoprim HPLC Dissolution Paddle apparatus
  • 相关文献

参考文献2

二级参考文献21

  • 1张连鹏,刘敬肖.药物涂层支架的研究进展[J].生物医学工程学杂志,2007,24(1):235-239. 被引量:6
  • 2ChP(中国药典).2005.Vol II(二部).Appendix(附录)X IX B.
  • 3The Dissolution Procedure Development and Validation. Pharmacopeial Forum,2004, 30( 1 ) :351.
  • 4Guidance for Industry:Dissolution Testing of Immediate Release Solid Oral Dosage Forms. httpt//www. fda. gov/cder/guidance/index. htm. 1997 - 08 - 25.
  • 5Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System(I). http://www. fda. gov/cder/guidance/index. htm. 2000 - 08 - 31.
  • 6国家食品药品监督管理局.化学药品制剂质量研究和质量标准制定指导原则(试行).
  • 7EMAMI J. Comparative in vitro and in vivo evaluation of three tablet formulations of amiodarone in healthy subjects[ J ], Daru, 2010,18(3) :193 - 199.
  • 8Guidance for Industry. The use of mechanical calibration of disso- lution apparatus 1 and 2-current Good Manufacturing Practice(CGMP) [ EB/OL]. [2012 - 01 - 22]. http://www, fda. gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guid- ances/UCM198649, pdf.
  • 9OCHEKPE NA, NGWULUKA NE, AGBOWURO AA,et al. Dissolution profiles of twelve brands of sulphadoxine pyrime- thamine in the nigerian market[ J]. Dissolut Technol, 2012, 19 (1) :59 -64.
  • 10BROWN CK, CHOKSHI HP, NICKERSON B, et al. Accepta- ble analytical practices for dissolution testing of poorly soluble compounds [ J ]. Pharm Technol, 2004, 28 ( 12 ) :56 - 65.

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部